* Adjusted by hospital group and previous infection status
Table 4 . Two-dose CoronaVac effectiveness against symptomatic PCR-confirmed COVID-19 infection for full cohort for entire study period a) when re-infection could occur 60 days (rather than 90 days) after infection; and b) when participants were considered fully vaccinated 7 days (rather than 14 days) after their second dose